ArticleOncotarget2016

Iciartin, a novel FASN inhibitor, exerts anti-melanoma activities through IGF-1R/STAT3 signaling.

Jinfeng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.